24th-26th October 2017
Clarion Congress Hotel,
Are biosimilars on your mind?
Do you have questions on market access, business and commercial strategies, regulatory and CMC, clinical and non-clinical developments? Let us provide you with the answers through regulatory agency advice, industry experts and in-depth discussion.
Where biosimilars professionals meet
With focus days on:
Market access, business and commercial strategies
Expert insight to answer your questions on the legal landscape, IP and patent protection, global commercialisation, co-development partnerships, benefits for the patient and the NHS, pricing and reimbursement for biosimilars.
Regulatory and CMC landscape
Ensure you are up to speed with the latest developments, including release of the long-awaited FDA interchangeability guidance and evolving EU and emerging markets requirements.
Clinical and non-clinical developments
Do you have your clinical and non-clinical strategies perfected? Benchmark yourself against numerous industry experts on designing and conducting clinical trials, comparing CQA, indication extrapolation for mAbs, non-clinical development hurdles, immunogenicity assays and “fingerprint”-like analysis.
Who can you hear from?
Where else can you find 200+ Pharmaceutical Regulatory Affairs, IDMP, eSubmissions and Biosimilars experts in the same place?
Combined with the Global Pharmaceutical Regulatory Affairs Summit
A new central European location. A focused agenda. And more opportunities for you to collaborate and connect.
The Event App
Browse the delegate list, access speaker presentations, set up one-to-one meetings and send messages to fellow participants. See updated content instantly, navigate around the venue with maps & floor plans, take part in surveys or polls, and swap your contact details.
Evening Drinks Reception
After a day of learning grab a drink and join your peers for an evening of socialising. Discuss the days content whilst sipping on an ice cold beverage and enjoying live entertainment.
Enhanced Networking 2017
For the first time ever, Biosimilars has come together with our Regulatory Affairs in Emerging Markets, IDMP Compliance and Global eSubmissions conference streams, providing enhanced networking opportunities and a platform for cross-functional discussion.